UVA Researchers Reveal Structure of Core Cellular Quality-Control Complex That Drives Human Disease
2/10/2026
Scientists at the University of Virginia School of Medicine have unveiled the first high-resolution structure of a central protein quality-control complex in human cells, illuminating how its malfunction drives disease.…
Research in Motion: Ian Wenker, PhD
2/10/2026
A big focus of [our] lab is trying to understand how the brain contributes to what's called sudden unexpected death in epilepsy. People with epilepsy—unfortunately some fraction of them—will experience…
School of Medicine Faculty Research Retreat Planned for Feb. 27
2/4/2026
Registration is open for the School of Medicine Research Retreat scheduled for Friday, Feb. 27, 2026 in the Newcomb Hall Ballroom. Please register for the retreat by Feb. 13 on…
Introducing Molecules to Medicines: A New Translational Science and Entrepreneurship Seminar Series
2/4/2026
The Manning Institute, together with the School of Medicine Office for Research and the Enterprise Studio at UVA Licensing & Ventures Group, is launching Molecules to Medicines, a new seminar…
Huiwang Ai, PhD, Appointed Director of the Center for Membrane and Cell Physiology
2/4/2026
Huiwang Ai, PhD, was appointed director of the Center for Membrane and Cell Physiology (CMCP) at the University of Virginia School of Medicine, effective Feb. 1, 2026. Ai is a…
Sepsis Study Identifies Easy Way to Save Lives in Africa
2/4/2026
Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis…
Research in Motion: Kelly Shaffer, PhD
2/4/2026
In our center, we build internet delivered programs that bring mental health to scale, and my work in particular focuses on helping cancer survivors and family caregivers with things like…
Scientists Identify Potential New Treatment for Deadliest Brain Cancer
2/4/2026
UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for the deadliest…
